arginine has been researched along with Hyperlipoproteinemia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breuer, ML; Havekes, LM; Hofker, MH; van der Boom, H; van der Zee, A; van Dijk, KW; van Gorp, PJ; van Vlijmen, BJ; van't Hof, HB | 1 |
Coetzee, GA; de Villiers, WJ; Henderson, HE; Marais, AD; van der Westhuyzen, DR | 1 |
Gylling, H; Huttunen, JK; Jauhiainen, M; Kantola, I; Kontula, K; Miettinen, HE; Miettinen, TA; Tenhunen, J; Virtamo, J | 1 |
Arner, P; Ehrenborg, E; Eriksson, P; Hamsten, A; Large, V; Ruotolo, G; Skogsberg, J | 1 |
4 other study(ies) available for arginine and Hyperlipoproteinemia
Article | Year |
---|---|
In the absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-158 --> Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice.
Topics: Animals; Apolipoproteins E; Arginine; Cells, Cultured; Cysteine; Genes, Dominant; Heymann Nephritis Antigenic Complex; Hyperlipoproteinemias; Lipoproteins, LDL; Lipoproteins, VLDL; Membrane Glycoproteins; Mice; Mice, Knockout; Mice, Transgenic; Receptors, LDL | 1996 |
The apolipoprotein E2 (Arg145Cys) mutation causes autosomal dominant type III hyperlipoproteinemia with incomplete penetrance.
Topics: Adolescent; Adult; Apolipoprotein E2; Apolipoproteins E; Arginine; Cholesterol, HDL; Cysteine; Female; Heterozygote; Homozygote; Humans; Hyperlipoproteinemias; Male; Middle Aged; Pedigree; Point Mutation; Polymorphism, Restriction Fragment Length; Restriction Mapping; Sequence Analysis, DNA; Triglycerides | 1997 |
Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels.
Topics: Adult; Arginine; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol Esters; Cholesterol, HDL; Cholesterol, LDL; Finland; Glycine; Glycoproteins; Humans; Hyperlipoproteinemias; Male; Mutation; Pedigree; Phosphatidylcholine-Sterol O-Acyltransferase; Polymerase Chain Reaction; Tangier Disease | 1998 |
The Q/E27 polymorphism in the beta2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins.
Topics: Adult; Alleles; Arginine; Body Weight; Cholesterol; Cholesterol, VLDL; Genotype; Glutamic Acid; Glutamine; Glycine; Humans; Hyperlipoproteinemias; Male; Middle Aged; Mutation; Polymorphism, Genetic; Receptors, Adrenergic, beta-2; Sweden; Triglycerides | 2000 |